Dose-Response Relationship Between Long-Term Blood Pressure Variability and Cognitive Decline.

TitleDose-Response Relationship Between Long-Term Blood Pressure Variability and Cognitive Decline.
Publication TypeJournal Article
Year of Publication2021
AuthorsLi, C, Ma, Y, Hua, R, Yang, Z, Zhong, B, Wang, H, Xie, W
JournalStroke
Volume52
Issue10
Pagination3249–3257
ISSN Number1524-4628
KeywordsBlood pressure, Cognitive decline, ELSA, Hypertension, Retirement
Abstract

BACKGROUND AND PURPOSE: We aimed to test whether higher long-term blood pressure variability was associated with accelerated rate of cognitive decline and evaluate potential dose-response relationship.

METHODS: Original survey data from the Health and Retirement Study and the English Longitudinal Study of Ageing were used. Standardized score of cognitive function was the main outcome measure. Visit-to-visit blood pressure SD, coefficient of variation, and variation independent of mean were used. Linear mixed model and restricted spline were applied to assess association and explore dose-response pattern. Segmented regression was used to analyze dose-response relationship and estimate turning point. Meta-analysis using random-effects model was conducted to pool results, with used to test heterogeneity.

RESULTS: A total of 12 298 dementia-free participants were included (mean age: 64.6±8.6 years). Significant association was observed between blood pressure variability and cognitive decline. Each 10% increment in coefficient of variation of systolic and diastolic blood pressure was associated with accelerated global cognitive decline of 0.026 SD/y (95% CI, 0.016-0.036, 0.001) and 0.022 SD/y (95% CI, 0.017-0.027, 0.001), respectively. Nonlinear dose-response relationship was found (0.001 for nonlinearity), with clear turning point observed (0.001 for change in slopes).

CONCLUSIONS: Higher long-term blood pressure variability was associated with accelerated cognitive decline among general adults aged ≥50 years, with nonlinear dose-response relationship. Further randomized controlled trials are warranted to evaluate potential benefits of blood pressure variability-lowering strategies from a cognitive health perspective.

DOI10.1161/STROKEAHA.120.033697
Citation Key11736
PubMed ID34167328